5WAF
ADC-7 in complex with boronic acid transition state inhibitor CR192
Summary for 5WAF
Entry DOI | 10.2210/pdb5waf/pdb |
Descriptor | Beta-lactamase, phosphonooxy-[[[4-(1~{H}-1,2,3,4-tetrazol-5-yl)-2-(trifluoromethyl)phenyl]sulfonylamino]methyl]borinic acid (3 entities in total) |
Functional Keywords | inhibitor, beta-lactamase, batsi, adc-7, antimicrobial protein, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Acinetobacter baumannii |
Total number of polymer chains | 4 |
Total formula weight | 164958.18 |
Authors | Powers, R.A.,Wallar, B.J. (deposition date: 2017-06-26, release date: 2017-12-06, Last modification date: 2023-10-04) |
Primary citation | Bouza, A.A.,Swanson, H.C.,Smolen, K.A.,VanDine, A.L.,Taracila, M.A.,Romagnoli, C.,Caselli, E.,Prati, F.,Bonomo, R.A.,Powers, R.A.,Wallar, B.J. Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C beta-Lactamase. ACS Infect Dis, 4:325-336, 2018 Cited by PubMed: 29144724DOI: 10.1021/acsinfecdis.7b00152 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.03 Å) |
Structure validation
Download full validation report